Long-term use of pramipexole in bipolar depression: A naturalistic retrospective chart review

Psychiatric Quarterly

Volumn 81, Issue 3, 2010, Pages 207-213

  El Mallakh, Rif S ^a   Penagaluri, Praveen ^a   Kantamneni, Arun ^a   Gao, Yonglin ^a   Roberts, Rona J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bipolar depression; Bipolar disorder; Long term outcome; Pramipexole

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE; CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROATE SEMISODIUM;

ADULT; AGITATION; ANOREXIA; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DIZZINESS; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; LETHARGY; LONG TERM CARE; MALE; MANIA; MEDICAL RECORD REVIEW; NATURALISTIC INQUIRY; NAUSEA; RATING SCALE; RETROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BENZOTHIAZOLES; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 78149357223     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-010-9130-6     Document Type: Article

References (29)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-Text Revision, 4th edn., revised. Arlington, Virginia, American Psychiatric Press, 2000
2. Calabrese JR, Bowden CL, Sachs GS, et al.: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression Lamictal 602 study group. Journal of Clinical Psychiatry 60:79-88, 1999
3. Calabrese JR, Bowden CL, Sachs GS, et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry 64:1013-1024, 2003
4. Calabrese JR, Keck PE Jr, Macfadden W, et al.: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry 162:1351-1360, 2005
5. Cassano P, Lattanzi L, Soldani F, et al.: Pramipexole in treatment-resistant depression: an extended follow up. Depression and Anxiety 20:131-138, 2004
6. El-Mallakh RS, Huff MO: Mood stabilizers and ion regulation. Harvard Review of Psychiatry 9:23-32, 2001
7. El-Mallakh RS, Karippot A: Chronic depression in bipolar disorder. American Journal of Psychiatry 163:1137-1341, 2006
8. El-Mallakh RS, Karippot A, Ghaemi SN: Antidepressants in Bipolar Depression. In: El-Mallakh RS, Ghaemi SN (Eds) Bipolar Depression: A Comprehensive Guide. Washington, DC, American Psychiatric Publishing, Inc., pp. 167-183, 2006
9. El-Mallakh RS, Weisler RH, Townsend MH, et al.: Bipolar II disorder: current and future treatment options. Annals of Clinical Psychiatry 18:259-266, 2006
10. Frye MA, Ketter TA, Kimbrell TA, et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology 20:607-614, 2000
11. Ghaemi SN, Boiman EE, Goodwin FK: Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. Journal of Clinical Psychiatry 61:804-808, 2000
12. Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs G, Goodwin FK, Baldessarini RJ: A randomized clinical trial of long-term effectiveness and safety of modern antidepressants combined with mood-stabilizers. Journal of Clinical Psychiatry, 2010 (in press)
13. Ghaemi SN, Lenox MS, Baldessarini RJ: Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. Journal of Clinical Psychiatry 62:565-569, 2001
14. Goldberg JF, Burdick KE, Endick CJ: Preliminary randomized, double blind, placebo controlled trial of pramipexole added to mood stabilizers for treatment resistant bipolar depression. American Journal of Psychiatry 161(3):564-566, 2004
15. Jensen NH, Rodriguiz RM, Caron MG, et al.: N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology 33:2303-2312, 2008
16. Judd LL, Akiskal HS, Schettler PJ, et al.: A prospective investigation of the natural history of the longterm weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry 60:261-269, 2003
17. Judd LL, Akiskal HS, Schettler PJ, et al.: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59:530-537, 2002
18. Kupka RW, Altshuler LL, Nolen WA, et al.: Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disorders 9(5):531-535, 2007
19. Maj J, Rogóż Z, Margas W, et al.: The effect of repeated treatment with pramipexole on the central dopamine D3 system. Journal of Neural Transmission 107:1369-1379, 2000 (Pubitemid 32049933)
20. Nierenberg AA, Ostacher MJ, Calabrese JR, et al.: Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. American Journal of Psychiatry 163:210-216, 2006
21. Nemeroff CB, Evans DL, Gyulai L, et al.: A double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry 158:906-912, 2001
22. Post RM, Leverich GS, Nolen WA, et al.: A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disorders 5:396-406, 2003
23. Roberts RJ, Yang M, El-Mallakh RS: Validity and reliability of the RAPID (Rapid Psychiatric Interview Data) scale. Presented at the Eighth International Conference on Bipolar Disorder, Pittsburgh, Pennsylvania, pp. 25-27, 2009
24. Sachs GS, Guille C, McMurrich SL: A clinical monitoring form for mood disorders. Bipolar Disorders 4:323-327, 2002
25. Sachs GS, Nierenberg AA, Calabrese JR, et al.: Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine 356(17):1711-1722, 2007
26. Spearing MK, Post RM, Leverich GS, et al.: Modification of clinical global impressions (GCI) scale for use in bipolar illness (BP): CGI-BP. Psychiatry Research 73:159-171, 1997
27. Vieta E, Suppes T, Eggens I, et al.: Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (International Trial 126). Journal of Affective Disorders 109:251-253, 2008
28. Wermuth L: A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease. European Journal of Neurology 5:235-242, 1998
29. Zarate CA Jr, Payne JL, Singh J, et al.: Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry 56(1):54-60, 2004